Innovations in Mycoplasma and Sterility Testing for Biopharma
Sterility and mycoplasma testing in biotherapies, particularly cell therapy products, is critical. Developing an analytical strategy to detect contaminants such as mycoplasma can present several challenges.
In this webinar, our expert speakers will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges. You’ll learn how to leverage rapid mycoplasma and sterility detection techniques early on in the therapy development workflow, which can significantly contribute to instilling confidence in the final product by facilitating the early detection of potential contamination.
Attend this webinar to discover:
- Strategies to overcome the challenges of traditional methods for product safety testing in cell therapy products
- The feature and benefits of using rapid detection techniques
- Learn how the throughput of our assays are scalable in order to meet or accommodate the increased testing requirements or needs following commercialization
- The latest regulatory guidelines for product safety testing in cell therapies